These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Endocannabinoid biosynthesis and inactivation, from simple to complex. Muccioli GG Drug Discov Today; 2010 Jun; 15(11-12):474-83. PubMed ID: 20304091 [TBL] [Abstract][Full Text] [Related]
3. Endocannabinoids: synthesis and degradation. Di Marzo V Rev Physiol Biochem Pharmacol; 2008; 160():1-24. PubMed ID: 18481028 [TBL] [Abstract][Full Text] [Related]
4. Targeted lipidomics as a tool to investigate endocannabinoid function. Astarita G; Geaga J; Ahmed F; Piomelli D Int Rev Neurobiol; 2009; 85():35-55. PubMed ID: 19607960 [TBL] [Abstract][Full Text] [Related]
5. The cannabinoid system and its pharmacological manipulation--a review, with emphasis upon the uptake and hydrolysis of anandamide. Fowler CJ Fundam Clin Pharmacol; 2006 Dec; 20(6):549-62. PubMed ID: 17109648 [TBL] [Abstract][Full Text] [Related]
6. The endocannabinoid system: drug targets, lead compounds, and potential therapeutic applications. Lambert DM; Fowler CJ J Med Chem; 2005 Aug; 48(16):5059-87. PubMed ID: 16078824 [No Abstract] [Full Text] [Related]
7. Membrane microdomains and metabolic pathways that define anandamide and 2-arachidonyl glycerol biosynthesis and breakdown. Placzek EA; Okamoto Y; Ueda N; Barker EL Neuropharmacology; 2008 Dec; 55(7):1095-104. PubMed ID: 18760289 [TBL] [Abstract][Full Text] [Related]
8. An introduction to the endocannabinoid system: from the early to the latest concepts. De Petrocellis L; Di Marzo V Best Pract Res Clin Endocrinol Metab; 2009 Feb; 23(1):1-15. PubMed ID: 19285257 [TBL] [Abstract][Full Text] [Related]
9. Endocannabinoids and their involvement in the neurovascular system. Battista N; Fezza F; Maccarrone M Curr Neurovasc Res; 2004 Apr; 1(2):129-40. PubMed ID: 16185189 [TBL] [Abstract][Full Text] [Related]
10. The endocannabinoid system and pain. Guindon J; Hohmann AG CNS Neurol Disord Drug Targets; 2009 Dec; 8(6):403-21. PubMed ID: 19839937 [TBL] [Abstract][Full Text] [Related]
11. Cannabinoid/Endocannabinoid signaling impact on early pregnancy events. Sun X; Dey SK Curr Top Behav Neurosci; 2009; 1():255-73. PubMed ID: 21104387 [TBL] [Abstract][Full Text] [Related]
12. Psychopharmacology of the endocannabinoids: far beyond anandamide. Pamplona FA; Takahashi RN J Psychopharmacol; 2012 Jan; 26(1):7-22. PubMed ID: 21652605 [TBL] [Abstract][Full Text] [Related]
13. Endocannabinoid metabolic pathways and enzymes. Ligresti A; Cascio MG; Di Marzo V Curr Drug Targets CNS Neurol Disord; 2005 Dec; 4(6):615-23. PubMed ID: 16375679 [TBL] [Abstract][Full Text] [Related]
14. Biosynthesis and inactivation of endocannabinoids: relevance to their proposed role as neuromodulators. Di Marzo V Life Sci; 1999; 65(6-7):645-55. PubMed ID: 10462065 [TBL] [Abstract][Full Text] [Related]
15. Cannabinoids biology: the search for new therapeutic targets. Felder CC; Dickason-Chesterfield AK; Moore SA Mol Interv; 2006 Jun; 6(3):149-61. PubMed ID: 16809476 [TBL] [Abstract][Full Text] [Related]
17. The endocannabinoid system: a general view and latest additions. De Petrocellis L; Cascio MG; Di Marzo V Br J Pharmacol; 2004 Mar; 141(5):765-74. PubMed ID: 14744801 [TBL] [Abstract][Full Text] [Related]
18. Therapeutic potential of the endocannabinoid system in the brain. Ramos JA; González S; Sagredo O; Gómez-Ruiz M; Fernández-Ruiz J Mini Rev Med Chem; 2005 Jul; 5(7):609-17. PubMed ID: 16026307 [TBL] [Abstract][Full Text] [Related]
19. Interactions of cannabidiol with endocannabinoid signalling in hippocampal tissue. Ryan D; Drysdale AJ; Pertwee RG; Platt B Eur J Neurosci; 2007 Apr; 25(7):2093-102. PubMed ID: 17419758 [TBL] [Abstract][Full Text] [Related]
20. Organized trafficking of anandamide and related lipids. Yates ML; Barker EL Vitam Horm; 2009; 81():25-53. PubMed ID: 19647107 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]